Dr. Mehta's study has an endpoint listed of October 2012. I wonder if that's on schedule?http://clinicaltrials.gov/ct2/show/NCT01089686
He presented data from patients four-months post-procedure at ISNVD last year, with QOL improvements.
Dr. Siskin's study has a primary completion date of August 2012 and an estimated completion date of August 2013, but they're still recruiting and we know that the Saskatchewan patients are at the earliest receiving treatment in March, for a trial that will run two years, so that would be March 2014.http://clinicaltrials.gov/ct2/show/NCT01201707
Both studies are in Albany.